Skip to content

Clinical trials

Dyskinesias trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Dyskinesias Country / region: United States Clear all

101 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20013
20025
20034
20045
20053
20062
20074
20083
20097
20106
20116
20124
20133
20149
20153
20165
20173
20181
20192
20214
20224
20231
20244
20251
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed69
Terminated16
Recruiting7
Withdrawn3
Suspended2
No longer available1
Enrolling by invitation1
Unknown status1
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Neurological Disorders and Stroke (NINDS)13
Adamas Pharmaceuticals, Inc.6
Great Lakes NeuroTechnologies Inc.6
Novartis Pharmaceuticals6
Oregon Health and Science University6
AbbVie (prior sponsor, Abbott)4
Addex Pharma S.A.3
Auspex Pharmaceuticals, Inc.3
Boston Children's Hospital3
EMD Serono3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Dyskinesias101
Parkinson Disease77
Movement Disorders22
Tremor12
Parkinsonian Disorders11
Nervous System Diseases9
Central Nervous System Diseases8
Chorea6
Neurologic Manifestations6
Hypokinesia5

Trials

Showing 76 to 100 of 101. Each trial links to its page on Pharma Observatory.

1 more trial matches. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.